Literature DB >> 7666893

Treatment of anogenital papillomavirus infections with an acyclic nucleoside phosphonate analogue.

R Snoeck, M Van Ranst, G Andrei, E De Clercq, S De Wit, M Poncin, N Clumeck.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7666893     DOI： 10.1056/NEJM199510053331418

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  8 in total

1.  Single-dose pharmacokinetics of cidofovir in continuous venovenous hemofiltration.

Authors:  Matthias G Vossen; Klaus-Bernhard Gattringer; Walter Jäger; Stefanie Kraff; Florian Thalhammer
Journal:  Antimicrob Agents Chemother       Date:  2014-01-13       Impact factor: 5.191

2.  Activities of various compounds against murine and primate polyomaviruses.

Authors:  G Andrei; R Snoeck; M Vandeputte; E De Clercq
Journal:  Antimicrob Agents Chemother       Date:  1997-03       Impact factor: 5.191

3.  Comparative study of the anti-human cytomegalovirus activities and toxicities of a tetrahydrofuran phosphonate analogue of guanosine and cidofovir.

Authors:  J Bedard; S May; M Lis; L Tryphonas; J Drach; J Huffman; R Sidwell; L Chan; T Bowlin; R Rando
Journal:  Antimicrob Agents Chemother       Date:  1999-03       Impact factor: 5.191

Review 4.  In search of a selective antiviral chemotherapy.

Authors:  E De Clercq
Journal:  Clin Microbiol Rev       Date:  1997-10       Impact factor: 26.132

Review 5.  Clinical potential of the acyclic nucleoside phosphonates cidofovir, adefovir, and tenofovir in treatment of DNA virus and retrovirus infections.

Authors:  Erik De Clercq
Journal:  Clin Microbiol Rev       Date:  2003-10       Impact factor: 26.132

6.  Alpha interferon augments cidofovir's antiviral and antiproliferative activities.

Authors:  Jeffrey A Johnson; J David Gangemi
Journal:  Antimicrob Agents Chemother       Date:  2003-06       Impact factor: 5.191

7.  Clinical pharmacokinetics of 1-[((S)-2-hydroxy-2-oxo-1,4,2-dioxaphosphorinan-5-yl)methyl]cytosine in human immunodeficiency virus-infected patients.

Authors:  K C Cundy; P Barditch-Crovo; B G Petty; A Ruby; M Redpath; H S Jaffe; P S Lietman
Journal:  Antimicrob Agents Chemother       Date:  1999-02       Impact factor: 5.191

8.  Cidofovir is active against human papillomavirus positive and negative head and neck and cervical tumor cells by causing DNA damage as one of its working mechanisms.

Authors:  Barbara Mertens; Tatiane Nogueira; Ruzena Stranska; Lieve Naesens; Graciela Andrei; Robert Snoeck
Journal:  Oncotarget       Date:  2016-07-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.